140 related articles for article (PubMed ID: 1845254)
1. Immunoreactivity of plasma parathyrin-related peptide: three region-specific radioimmunoassays and a two-site immunoradiometric assay compared.
Ratcliffe WA; Norbury S; Stott RA; Heath DA; Ratcliffe JG
Clin Chem; 1991 Oct; 37(10 Pt 1):1781-7. PubMed ID: 1845254
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an immunoradiometric assay of parathyrin-related protein in unextracted plasma.
Ratcliffe WA; Norbury S; Heath DA; Ratcliffe JG
Clin Chem; 1991 May; 37(5):678-85. PubMed ID: 2032320
[TBL] [Abstract][Full Text] [Related]
3. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
[TBL] [Abstract][Full Text] [Related]
4. A high abundance midregion species of parathyroid hormone-related protein: immunological and chromatographic characterization in plasma.
Burtis WJ; Dann P; Gaich GA; Soifer NE
J Clin Endocrinol Metab; 1994 Feb; 78(2):317-22. PubMed ID: 8106619
[TBL] [Abstract][Full Text] [Related]
5. Production and characterisation of monoclonal antibodies to the mid-region 37-67 sequence of parathyroid hormone-related protein.
Ratcliffe WA; Bowden SJ; Emly J; Hughes S; Ratcliffe JG
J Immunol Methods; 1992 Jan; 146(1):33-42. PubMed ID: 1370959
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure.
Orloff JJ; Soifer NE; Fodero JP; Dann P; Burtis WJ
Kidney Int; 1993 Jun; 43(6):1371-6. PubMed ID: 8315952
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
9. Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay.
Blind E; Raue F; Meinel T; Bucher M; Manegold C; Ebert W; Vogt-Moykopf I; Ziegler R
Clin Investig; 1993 Jan; 71(1):31-6. PubMed ID: 8453257
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid-hormone-related peptide immunochemiluminometric assay. Developed with polyclonal antisera produced from a single animal.
Wu TJ; Taylor RL; Kao PC
Ann Clin Lab Sci; 1997; 27(5):384-90. PubMed ID: 9303178
[TBL] [Abstract][Full Text] [Related]
11. In vitro stability of endogenous parathyroid hormone-related protein in blood and plasma.
Hutchesson AC; Hughes SV; Bowden SJ; Ratcliffe WA
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():35-9. PubMed ID: 7512317
[TBL] [Abstract][Full Text] [Related]
12. Severe humoral hypercalcemia in primary isolated non-Hodgkin's lymphoma of the heart.
Yigla M; Ben-Arieh Y; Beny A; Milo S; Markiewicz W; Reisner SA
Med Pediatr Oncol; 1997 Mar; 28(3):183-6. PubMed ID: 9024513
[TBL] [Abstract][Full Text] [Related]
13. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
[TBL] [Abstract][Full Text] [Related]
14. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.
Nussbaum SR; Zahradnik RJ; Lavigne JR; Brennan GL; Nozawa-Ung K; Kim LY; Keutmann HT; Wang CA; Potts JT; Segre GV
Clin Chem; 1987 Aug; 33(8):1364-7. PubMed ID: 3608153
[TBL] [Abstract][Full Text] [Related]
17. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism.
Endres DB; Villanueva R; Sharp CF; Singer FR
Clin Chem; 1991 Feb; 37(2):162-8. PubMed ID: 1993319
[TBL] [Abstract][Full Text] [Related]
18. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies.
Bouillon R; Coopmans W; Degroote DE; Radoux D; Eliard PH
Clin Chem; 1990 Feb; 36(2):271-6. PubMed ID: 1689222
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
20. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.
Pandian MR; Morgan CH; Carlton E; Segre GV
Clin Chem; 1992 Feb; 38(2):282-8. PubMed ID: 1371724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
